Drug Profile
Muromonab CD3
Alternative Names: Anti-CD3 monoclonal antibody OKT3; Monoclonal antibody OKT3; OKT-3; OKT3 antibody; Orthoclone OKT-3Latest Information Update: 24 Oct 2021
Price :
$50
*
At a glance
- Originator Johnson & Johnson
- Class Antivirals; Monoclonal antibodies
- Mechanism of Action Antibody-dependent cell cytotoxicity; CD3 antigen inhibitors; Immunosuppressants; T lymphocyte stimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Marketed Heart transplant rejection; Liver transplant rejection; Renal transplant rejection
- Discontinued Cancer; Renal cancer